Apatinib for Advanced Lung Squmamous Carcinoma
NCT03725423
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Lung Squamous Cell Carcinoma
Interventions
DRUG:
Apatinib
Sponsor
Xuzhou Central Hospital